PO.6.119 Low-dose belimumab and antimalarial agents prevent renal flares in systemic lupus erythematosus: results from four randomised clinical trials

• A Gómez,
• I Parodis,
• C Sjöwall,
• S Jägerback

Affiliations

A Gómez

Rheumatology, Hospital Clinic, Barcelona, Spain

I Parodis

1Karolinska Institutet, Stockholm, Sweden

C Sjöwall

2Linköping University, Linköping, Sweden

S Jägerback

Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital ~ Stockholm ~ Sweden